Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 30:2024:5550362.
doi: 10.1155/2024/5550362. eCollection 2024.

Hypoperfusion in Supramarginal and Orbital Gyrus, Position Discrimination Test, and Microsaccades as a Predictor of Pisa Syndrome in Parkinson's Disease

Affiliations

Hypoperfusion in Supramarginal and Orbital Gyrus, Position Discrimination Test, and Microsaccades as a Predictor of Pisa Syndrome in Parkinson's Disease

Asako Yoritaka et al. Parkinsons Dis. .

Abstract

Patients with Parkinson's disease (PD) experience significantly reduced quality of life when PD is complicated with Pisa syndrome (PS). PS is a postural abnormality associated with a lateral bending of the trunk, causing the patient to lean to one side. Microsaccades during fixation are transmitted to the visual cortex, and this gaze movement may be impaired in PD. We aimed to detect presymptomatic signs of PS. We enrolled 50 patients with PD without dementia and investigated the visual systems in patients with concurrent PD and PS based on a Romberg ratio of<1.0. Gaze analysis, pupil diameter, stabilization tests, neuropsychological tests, and cerebral perfusion scintigraphy were reviewed and statistically analyzed. Two years later, we divided the patients into three groups as follows: PISA++ (patients who had PS at enrollment), PISA-+ (patients without PS that developed PS during the 2-year period), and PISA-- (patients without PS that did not develop PS during the 2-year period). The PISA-+ group exhibited a significantly higher daily levodopa dose and longer fixations, as well as lower position discrimination, Wechsler Adult Intelligence Scale-Third Edition blocking, and blood flow in the left supramarginal and orbital gyri than that in the PISA-- group. The PISA++ group showed a significantly longer fixation time and lower Mini-Mental State Examination score, Romberg ratio of area, amplitude, velocity of microsaccades, and blood flow in the left precuneus and cuneus than that in the PISA-+ group. Before the onset of PS, hypoperfusion occurred in the correlative visual cortex and the position discrimination test. Patients with PS have reduced saccades and slow microsaccades.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflicts of interest regarding the publication of this article. AY received speaker honoraria from Kyowa Kirin Co., Ltd., Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., and Eisai Pharmaceutical Co., Ltd. NH was an advisory member of Sumitomo Pharma Co., Ltd., Hisamitsu Pharmaceutical Co., Inc., and Biogen Idec Japan Ltd., received lecture fees from Sumitomo Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kyowa Kirin Co., Ltd., FP Pharmaceutical Corporation, Eisai Co., Ltd., and AbbVie GK, and received departmental endowments by commercial entities from Kyowa Kirin Co., Ltd., Nippon Boehringer Ingelheim, Co., Ltd., AbbVie GK, FP Pharmaceutical Corporation, Otsuka Pharmaceutical, Co., Ltd., Dai-Nippon Sumitomo Pharma Co., Ltd., Eisai Co., Ltd., Nihon Medi-Physics Co., Ltd., Asahi Kasei Medical Co., Ltd., Ono Pharmaceutical Co., Ltd., MiZ Co., Ltd., AbbVie GK, OHARA Pharmaceutical Co., Ltd., Nihon Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Boston Scientific Corporation, and Medtronic Inc.

Figures

Figure 1
Figure 1
Decision tree model to optimize the PISA+ using the clinical findings at enrollment. The combination of disease duration >6 years and length during eye opening (gravicorder) >95 cm resulted in PISA+. A combination of disease duration <6 years and position discrimination test score <18 points resulted in PISA+.
Figure 2
Figure 2
123I-IMP single-photon emission computed tomography (SPECT) findings of the three groups. 3DSSP was used to compare hypoperfusion among the three groups. The SPECT images from the participants were spatially transformed into a Talairach Atlas. Significant differences were defined by Z scores ≥2.5. PISA-+ vs. PISA-- shows hypoperfusion in the left supramarginal and orbital gyri. PISA++ vs. PISA-+ shows hypoperfusion in the left precuneus, cuneus, and superior temporal gyrus. PISA++ vs. PISA-- shows hypoperfusion in the left precuneus and cuneus.
Figure 3
Figure 3
Clinical model of Pisa syndrome in patients with Parkinson's disease. In the stage of preclinical Pisa syndrome, perfusion of the frontal orbital gyrus and supramarginal area and position discrimination score were decreased. In Pisa syndrome, perfusion of the precuneus and cuneus was decreased, and the Romberg rate of the area was <1.0. The amplitude and velocity of microsaccades were decreased in Pisa syndrome. SPECT, single-photon emission computed tomography.

Similar articles

Cited by

  • Pisa Syndrome Secondary to Drugs: A Scope Review.
    Pitton Rissardo J, Murtaza Vora N, Danaf N, Ramesh S, Shariff S, Fornari Caprara AL. Pitton Rissardo J, et al. Geriatrics (Basel). 2024 Jul 30;9(4):100. doi: 10.3390/geriatrics9040100. Geriatrics (Basel). 2024. PMID: 39195130 Free PMC article. Review.

References

    1. Ben-Shlomo Y., Marmot M. G. Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? Journal of Neurology, Neurosurgery & Psychiatry . 1995;58(3):293–299. doi: 10.1136/jnnp.58.3.293. - DOI - PMC - PubMed
    1. Diem-Zangerl A., Seppi K., Wenning G. K., et al. Mortality in Parkinson’s disease: a 20-year follow-up study. Movement Disorders . 2009;24(6):819–825. doi: 10.1002/mds.22414. - DOI - PubMed
    1. Yoritaka A., Shimo Y., Hatano T., Hattori N. Motor/nonmotor symptoms and progression in patients with Parkinson’s disease: prevalence and risks in a longitudinal study. Parkinson’s Disease . 2020;2020:13. doi: 10.1155/2020/2735361.2735361 - DOI - PMC - PubMed
    1. Tinazzi M., Geroin C., Gandolfi M., et al. Pisa syndrome in Parkinson’s disease: an integrated approach from pathophysiology to management. Movement Disorders . 2016;31(12):1785–1795. doi: 10.1002/mds.26829. - DOI - PubMed
    1. Artusi C.A., Montanaro E., Erro R., et al. Visuospatial deficits are associated with Pisa syndrome and not camptocormia in Parkinson’s disease. Movement Disorders Clinical Practice . 2023;10(1):64–73. doi: 10.1002/mdc3.13605. - DOI - PMC - PubMed

LinkOut - more resources